戻る
VISEN Pharmaceuticals (02561.HK)価格
02561.HK 株価推移チャート
VISEN PHARMA-B (02561.HK)
VISEN Pharmaceuticals
HK$33.8
-1.51%
$-0.52
休場: Jan 16, 16:00:00 HKT
主要データ
前終値
$34.42
始値
$34.32
当日レンジ
$33.1 - $34.32
52週レンジ
$29.06 - $69.15
取引高
15.6K
平均取引高
32.8K
1株当たり利益(TTM)
-2.12
配当利回り
--
時価総額
$3.8B
VISEN PHARMA-Bとは何ですか？
VISEN Pharmaceuticals operates as a biopharmaceutical company. The company is headquartered in Suzhou, Jiangsu and currently employs 54 full-time employees. The company went IPO on 2025-03-21. The firm's main products under development include lonapegsomatropin, navepegritide, and palopegteriparatide. The lonapegsomatropin is used to treat growth hormone deficiency in children aged 3 to 17 years old. The navepegritide is a disease repair therapy used to treat children with cartilage dysplasia aged 2 to 10 years old. The palopegteriparatide is a treatment method used to treat adult hypoparathyroidism. The firm is in the late stage of research and development, and its products are close to commercialization.
